Hauck & Aufhäuser Privatbankiers KGaA reported on Gerresheimer (ETR:GXI), upping its target price to 80.00EUR today
- Updated: October 6, 2016
Yesterday Gerresheimer (ETR:GXI) traded 0.00% even at 74.35EUR. The company’s 50-day moving average is 0.00EUR and its 200-day moving average is 0.00EUR. The last closing price is up 0.00% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time period. 0 shares of the stock traded hands, down from an average trading volume of 0
Hauck & Aufhäuser Privatbankiers KGaA raised the target price of Gerresheimer (ETR:GXI) to 80.00EUR reporting a potential upside of 0.08%.
Previously on 10/05/2016, Hauck & Aufhäuser Privatbankiers KGaA reported on Gerresheimer (ETR:GXI) increased the target price from 0.00EUR to 80.00EUR. At the time, this indicated a possible upside of 0.05%.
See Chart Below
Gerresheimer has a 52 week low of 0.00EUR and a 52 week high of 0.00EUR The company’s market cap is currently 0 EUR.
General Information About Gerresheimer (ETR:GXI)
Gerresheimer AG is a Germany-based company that operates in the pharmaceuticals and health care industry. It is structured in three business segments: Plastic and Devices, Primary Packaging Glass and Life Science Research. The Company produces pharmaceutical packaging products, as well as drug-delivery systems made out of glass and plastics or a combination of both. Its product portfolio includes insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.